SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-15-000053
Filing Date
2015-09-09
Accepted
2015-09-09 13:36:37
Documents
5
Period of Report
2015-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201508318-k.htm 8-K 36586
2 EXHIBIT 10.1 lindemannemploymentagreeme.htm EX-10.1 70008
3 EXHIBIT 99.1 a20150909pressrelease.htm EX-99.1 10611
4 EXHIBIT 99.2 a20150908pressrelease.htm EX-99.2 9009
5 image1.gif GRAPHIC 65192
  Complete submission text file 0001615219-15-000053.txt   217318
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 151098549
SIC: 2834 Pharmaceutical Preparations